- Home
- ITIC vs VANI Comparison
ITIC vs VANI Comparison
Compare ITIC & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- VANI
- Stock Information
- Founded
- ITIC 1972
- VANI 1998
- Country
- ITIC United States
- VANI United States
- Employees
- ITIC N/A
- VANI N/A
- Industry
- ITIC Specialty Insurers
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ITIC Finance
- VANI Health Care
- Exchange
- ITIC Nasdaq
- VANI Nasdaq
- Market Cap
- ITIC 440.1M
- VANI 68.1M
- IPO Year
- ITIC N/A
- VANI 2014
- Fundamental
- Price
- ITIC $214.00
- VANI $1.30
- Analyst Decision
- ITIC
- VANI Strong Buy
- Analyst Count
- ITIC 0
- VANI 1
- Target Price
- ITIC N/A
- VANI $4.00
- AVG Volume (30 Days)
- ITIC 76.9K
- VANI 156.1K
- Earning Date
- ITIC 08-05-2025
- VANI 08-12-2025
- Dividend Yield
- ITIC 7.42%
- VANI N/A
- EPS Growth
- ITIC 18.56
- VANI N/A
- EPS
- ITIC 15.69
- VANI N/A
- Revenue
- ITIC $261,197,999.00
- VANI N/A
- Revenue This Year
- ITIC N/A
- VANI N/A
- Revenue Next Year
- ITIC N/A
- VANI N/A
- P/E Ratio
- ITIC $13.73
- VANI N/A
- Revenue Growth
- ITIC 15.27
- VANI N/A
- 52 Week Low
- ITIC $174.00
- VANI $0.91
- 52 Week High
- ITIC $290.40
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- ITIC 49.20
- VANI 71.88
- Support Level
- ITIC $204.58
- VANI $1.13
- Resistance Level
- ITIC $211.04
- VANI $1.33
- Average True Range (ATR)
- ITIC 5.33
- VANI 0.07
- MACD
- ITIC 1.98
- VANI 0.01
- Stochastic Oscillator
- ITIC 94.38
- VANI 81.82
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.